Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study
Crossref DOI link: https://doi.org/10.1007/s12253-016-0129-7
Published Online: 2016-10-22
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kószó, Renáta
Sántha, Dóra
Büdi, László
Erfán, József
Győrfy, Károly
Horváth, Zsolt
Kocsis, Judit
Landherr, László
Hitre, Erika
Máhr, Károly
Pajkos, Gábor
Pápai, Zsuzsanna
Kahán, Zsuzsanna
License valid from 2016-10-22